Skip to content

Opening book details…

About this Medicine article

Efficacy of lanreotide Autogel® administered every 4–8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: a phase III trial by T. Lucas; R. Astorga; ; the Spanish–Portuguese Multicentre Autogel Study Group on Acromegaly is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
T. Lucas; R. Astorga; ; the Spanish–Portuguese Multicentre Autogel Study Group on Acromegaly
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley; Research Square (ISSN 0300-0664)
Published
2006
Field
Medicine (Health Sciences)

More by T. Lucas; R. Astorga; ; the Spanish–Portuguese Multicentre Autogel Study Group on Acromegaly

Browse all works by T. Lucas; R. Astorga; ; the Spanish–Portuguese Multicentre Autogel Study Group on Acromegaly